Pulmonology

Doç. Dr. Özgür Batum

Doctor and researcher İzmir Şehir Hastanesi İzmir
Lung NeoplasmsCOVID-19Pulmonary EmbolismAdenocarcinoma of LungCarcinoma, Non-Small-Cell Lung
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lung Neoplasms 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • COVID-19 5 publications
  • Pulmonary Embolism 2 publications
  • Adenocarcinoma of Lung 2 publications
  • Carcinoma, Non-Small-Cell Lung 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPulmonologysaglik.gov.trFrom source
  • Institutionİzmir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workLung NeoplasmsExtracted from 8 publications · Model version —From source
  • Publications79 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-8353-3421ORCIDFrom source
  • Last synchronised5 November 2026 09:07https://izmirsehir.saglik.gov.tr/TR-1046714/doktorlarimiz.html#ozgur-batumsaglik.gov.tr

Scientific work

Publications on Lung Neoplasms

79 publications

  1. Predictors of 90-Day Mortality and the Association of Reperfusion Therapy with 90-Day Mortality in Intermediate-High and High-Risk Pulmonary Embolism: A Real-World Multidisciplinary Cohort Study

    Life, 2026

    DOI 10.3390/life16071189 PMID 42514256 Open-access full textSource: ORCID

  2. B67-20 Thrombolysis and 90-Day Mortality in High- And Intermediate-High-Risk Pulmonary Embolism: A Real-World Cohort Study

    American Journal of Respiratory and Critical Care Medicine, 2026

    DOI 10.1093/ajrccm/aamag162.5721 Source: OpenAlex

  3. Can Thoracic CT Features Predict Mutation Positivity in Stage IV Lung Adenocarcinoma? A Retrospective Analysis of 810 Cases

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1019 Source: OpenAlex

  4. Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism

    International Journal of Molecular Sciences, 2026

    DOI 10.3390/ijms27020758 PMID 41596405 Open-access full textSource: ORCID

  5. Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study

    Therapeutic Advances in Respiratory Disease, 2026

    DOI 10.1177/17534666261475558 PMID 42671912 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. Late-Onset Nivolumab-Induced Pneumonitis in Metastatic Lung Adenocarcinoma: A Case Report

    Journal of İzmir Chest Hospital, 2026

    DOI 10.14744/igh.2026.06977 Open-access full textSource: OpenAlex

  7. Comparison of NEWS-2, CURB-65, A-DROP, and MuLBSTA Scores for Predicting In-Hospital Mortality and Intensive Care Unit Admission in Patients Hospitalized with COVID-19 Pneumonia

    Journal of İzmir Chest Hospital, 2026

    DOI 10.14744/igh.2026.41033 Open-access full textSource: OpenAlex

  8. Multidimensional Geriatric Assessment Improves Risk Stratification Beyond Conventional Pneumonia Severity Scores

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2898 Source: OpenAlex

  9. The association of metabolic positron emission tomography/computed tomography parameters with survival in small cell lung cancer

    Annals of Saudi Medicine, 2025

    DOI 10.5144/0256-4947.2025.25 PMID 39929786 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. A Rare Causative Agent in Hospital-acquired Pneumonia: Hafnia Alvei

    Respiratory Case Reports, 2025

    DOI 10.5505/respircase.2025.46578 Open-access full textSource: OpenAlex

View all 79 publications